IRIS
DALLABONA, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.775
EU - Europa 2.443
AS - Asia 1.760
SA - Sud America 220
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 7.233
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.730
IT - Italia 736
CN - Cina 680
SG - Singapore 595
SE - Svezia 443
IE - Irlanda 424
HK - Hong Kong 265
FI - Finlandia 222
BR - Brasile 200
DE - Germania 154
NL - Olanda 111
FR - Francia 86
GB - Regno Unito 66
TR - Turchia 60
UA - Ucraina 58
RU - Federazione Russa 56
BD - Bangladesh 45
IN - India 41
BE - Belgio 29
CA - Canada 29
AT - Austria 22
PK - Pakistan 11
CI - Costa d'Avorio 10
VN - Vietnam 10
AR - Argentina 9
KR - Corea 9
MX - Messico 9
ES - Italia 8
IR - Iran 7
EU - Europa 6
ID - Indonesia 6
LT - Lituania 5
PL - Polonia 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
IL - Israele 4
KE - Kenya 4
MA - Marocco 4
PT - Portogallo 4
VE - Venezuela 4
DK - Danimarca 3
EG - Egitto 3
IQ - Iraq 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AU - Australia 2
CO - Colombia 2
JM - Giamaica 2
JP - Giappone 2
LB - Libano 2
LK - Sri Lanka 2
PE - Perù 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
EC - Ecuador 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TM - Turkmenistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 7.233
Salva come PNG Salva come JPEG
Città #
Dublin 413
Chandler 376
Santa Clara 374
Singapore 352
Hong Kong 256
Parma 196
Beijing 178
Ann Arbor 172
Ashburn 170
Dearborn 142
Boardman 137
Jacksonville 83
Shanghai 82
Nanjing 79
Princeton 69
New York 61
Izmir 54
Los Angeles 43
Wilmington 43
Moscow 41
Columbus 38
Munich 36
Helsinki 33
Des Moines 31
Jinan 30
Milan 30
Bologna 28
Brussels 28
Nanchang 28
Shenyang 27
San Mateo 26
Woodbridge 25
Hefei 23
Kunming 22
Marseille 22
Nuremberg 22
Hebei 18
Toronto 18
Changsha 16
São Paulo 16
Colchester 15
Guangzhou 15
Hangzhou 15
Turku 15
Dallas 14
Falls Church 14
Seattle 14
Tianjin 14
Redmond 13
Rome 13
Catania 12
The Dalles 12
Vienna 12
Zhengzhou 12
Belo Horizonte 11
Fontanellato 11
Abidjan 10
Bengaluru 10
Frankfurt am Main 10
Piacenza 10
Bremen 9
Houston 9
Pistoia 9
Seoul 9
Bari 8
Norwalk 8
Pune 8
Vicenza 8
Washington 8
Chicago 7
Gravina di Catania 7
Vezzano sul Crostolo 7
Carpi 6
Council Bluffs 6
Dosolo 6
Haikou 6
Jakarta 6
Grafing 5
Guarulhos 5
Ho Chi Minh City 5
Langhirano 5
Mardan 5
Newcastle Upon Tyne 5
Ottawa 5
Reggio Nell'emilia 5
Rio de Janeiro 5
Trezzano Sul Naviglio 5
Arnstadt 4
Avola 4
Baku 4
Benevento 4
Brescia 4
Cagliari 4
Curitiba 4
Ferrara 4
Glen Mills 4
Jiaxing 4
Messina 4
Mexico City 4
Nairobi 4
Totale 4.319
Salva come PNG Salva come JPEG
Nome #
DNA polymerase [gamma] and disease: what we have learned from yeast 143
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 141
Yeast as a model system to shed light on the role of the human disease protein Mpv17 131
Elongator-dependent modification of cytoplasmic tRNALysUUU is required for mitochondrial function under stress conditions 125
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive externalophthalmoplegia in humans 123
Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration 123
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 122
Sabotage at the powerhouse? Unraveling the Molecular Target of 2-Isopropylbenzaldehyde Thiosemicarbazone, a Specific Inhibitor of Aflatoxin Biosynthesis and Sclerotia Development in Aspergillus flavus, Using Yeast as a Model System 120
Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function 115
Pathogenic variants in glutamyl-tRNAGlnamidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder 113
YEAST MODEL FOR NOVEL AARS2 MUTATIONS ASSOCIATED WITH PROGRESSIVE LEUKOENCEPHALOPATHY AND CEREBELLAR ATAXIA 112
Yeast as a model system for diseases associated with defective coenzyme a metabolism 112
A single nucleotide polymorphism in the DNA polymerase gamma gene of Saccharomyces cerevisiae laboratory strains is responsible for increased mitochondrial DNA mutability 110
A homozygous mutation in LYRM7/MZM1L associated with early onset encephalopathy, lactic acidosis and severe reduction of mitochondrial complex III activity. 110
A Novel Homozygous YARS2 Mutation in Two Italian Siblings and a Review of Literature 107
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 106
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 105
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy 104
Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex 103
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation 102
Genetic, physiological and molecular characterization of MPV17/SYM1 mutations in S. cerevisiae 102
Decline of cardiomyocyte contractile performance and bioenergetic function in socially stressed male rats 99
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae 99
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 96
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 94
TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies 94
Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair 94
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 94
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 94
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 94
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 94
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 93
Characterization of the Saccharomyces cerevisiae SYM1 gene, ortholog of the human desease gene MPV17 93
Sideroblastic anemia with myopathy secondary to novel, pathogenic missense variants in the YARS2 gene 93
MUTATIONS IN THE GENES QRSL1, GATB, AND GATC ENCODING THE SUBUNITS OF GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE CAUSE A MITOCHONDRIAL DISORDER WITH LETHAL INFANTILE CARDIOMYOPATHY 92
SYM1, l'ortologo di lievito del gene umano MPV17, codifica per una proteina indotta da stress che modula lo stato bioenergetico e morfogenetico del mitocondrio 91
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 91
Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism 90
Pathological Role of Mutations in Human MPV17: Saccharomyces cerevisiae as a Model System 89
Mitochondrial Aminoacyl-tRNA Synthetase: The Power Of Yeast In Modeling Human Pathological Mutations 89
VARS2 and TARS2 Mutations in Patients with Mitochondrial Encephalomyopathies 88
LYRM7 mutations cause a multifocal cavitating leukoencephalopathy with distinct MRI appearance. 87
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 87
Saccharomyces cerevisiae, a model system to study the effect of mtDNA polymerase mutations associated with PEO in humans. 86
Mutations in the mitochondrial tryptophanyl-tRNA synthetase cause growth retardation and progressive leukoencephalopathy 85
Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model 84
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 84
DEFECTIVE MITOCHONDRIAL rRNA METHYLTRANSFERASE (MRM2) CAUSES A MELAS-LIKE SYNDROME 82
In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration 81
The power of yeast in modeling human mutations: mitochondrial aminoacyl tRNA synthetases and mitochondrial tRNA modifiers 80
Research of potentially therapeutic molecules for Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 80
Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae 78
Case Series and DARS2 Variant Analysis in Early Severe Forms With Unexpected Presentations 78
Pathogenic variants in GCSH encoding the moonlighting H-protein cause combined Nonketotic Hyperglycinemia and Lipoate Deficiency 77
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 77
Study of the effects of potentially beneficial molecules on the mitochondrial dNTP pool in a model of Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 77
MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast 75
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 75
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 75
The Saccharomyces cerevisiae yeast as a model system to study the human mitochondrial DNA depletion syndromes (MDDS) 73
Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease Models 73
MITMED: A MULTICENTER CONSORTIUM FOR THE IDENTIFICATION AND CHARACTERIZATION OF NUCLEAR GENES RESPONSIBLE FOR HUMAN MITOCHONDRIAL DISORDERS 72
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. 71
Functional analysis of missense DARS2 variants in siblings with leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation 67
The power of yeast in modeling human mutations leading to mitochondrial disease 67
Repeated witness social stress causes cardiomyocyte contractile impairment and intracellular Ca2+ derangement in female rats 67
Epigenetic alterations in prescription opioid misuse: New strategies for precision pain management 65
Mitochondrial aminoacyl‐trna synthetase and disease: The yeast contribution for functional analysis of novel variants 65
Mitochondrial diseases and the role of the yeast models. 64
Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number 64
Role of ROS in mtDNA instability in ANT1-associated adPEO 63
Yeast models of human MTO1 variants confirm two diagnoses of mitochondrial modopathy 61
The first recessive pathological mutation in the adenine nucleotide translocator: yeast as a model system 61
Novel (ovario) leukodystrophy related to AARS2 mutations 60
Yeast-based screening to discover therapies for Complex III assembly defects. 52
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis 49
Epigenetic analyses in forensic medicine: future and challenges 48
MTO1 MUTATIONS CAUSE RESPIRATORY CHAIN DEFICIENCY IN HUMANS AND YEAST 45
Yeast model of mitochondrial involvement of Aβ amyloidotic neurodegeneration 44
A potential link between inflammatory profiles, clinical pain, pain catastrophizing and long‐term outcomes after total knee arthroplasty surgery 41
Characterization of the BCS1L c.38A>G variant identified in a patient with Biörnstad syndrome 41
Phenotypic, molecular, and functional characterization of COQ7-related primary CoQ10 deficiency: Hypomorphic variants and two distinct disease entities 41
The Saccharomyces cerevisiae mitochondrial DNA polymerase and its contribution to the knowledge about human POLG-related disorders 40
A simple organism to address big questions: how Saccharomyces cerevisiae can support mitochondrial medicine 39
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 38
Transcriptomics on yeast models to deepen the knowledge of mitochondrial disease-associated pathways 36
The yeast Saccharomyces cerevisiae as a model to deepen the knowledge about the mitochondrial metallopeptidase PITRM1 in health and disease 36
The polymorphism Val158Met in the COMT gene: disrupted dopamine system in fibromyalgia patients? 34
De novo DNM1L pathogenic variant associated with lethal encephalocardiomyopathy and a literature review 33
Pain mechanistic networks: the development using supervised multivariate data analysis and implications for chronic pain 30
Targeting defects in assembly of the mitochondrial respiratory chain complexes by exploiting yeast models 28
Identification of potential therapeutic compounds for mitochondrial disorders due to mutations in mitochondrial respiratory chain assembly factors by exploiting yeast models 28
An Unusual Case of SUCLA2-related Mitochondrial DNA Depletion Syndrome Who Presented with Hepatopathy Following Chemotherapy: Molecular Analysis and Functional Study 27
Saccharomyces cerevisiae: a powerful organism to study mitochondrial diseases and support mitochondrial medicine 27
Childhood obsessive-compulsive disorder, epigenetics, and heterochrony: An evolutionary and developmental approach 12
De Novo DNM1L Pathogenic Variant Associated with Lethal Encephalocardiomyopathy—Case Report and Literature Review 6
Totale 7.506
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.185
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.185
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021463 8 22 46 5 48 31 23 23 106 61 53 37
2021/2022407 22 21 1 27 14 27 36 37 14 33 28 147
2022/20231.478 141 151 102 96 136 157 28 83 505 7 51 21
2023/2024764 57 66 37 29 58 146 39 64 17 74 66 111
2024/20252.559 44 91 123 143 291 388 142 116 359 205 193 464
2025/2026137 137 0 0 0 0 0 0 0 0 0 0 0
Totale 7.506